Anji Pharma snags $70M for phase 3 diabetes and mid-stage asset
29 Sep 2021 //
FIERCEBIOTECH
Anji Pharms Licenses Regional Rights to a Clinical Asset from Global Pharma
18 Dec 2018 //
BIOSPACE
29 Sep 2021 //
FIERCEBIOTECH
18 Dec 2018 //
BIOSPACE